全文获取类型
收费全文 | 37260篇 |
免费 | 2793篇 |
国内免费 | 1887篇 |
专业分类
耳鼻咽喉 | 290篇 |
儿科学 | 448篇 |
妇产科学 | 246篇 |
基础医学 | 6777篇 |
口腔科学 | 706篇 |
临床医学 | 3766篇 |
内科学 | 6192篇 |
皮肤病学 | 179篇 |
神经病学 | 3755篇 |
特种医学 | 1914篇 |
外国民族医学 | 1篇 |
外科学 | 5166篇 |
综合类 | 4414篇 |
现状与发展 | 6篇 |
预防医学 | 1433篇 |
眼科学 | 612篇 |
药学 | 3655篇 |
10篇 | |
中国医学 | 1337篇 |
肿瘤学 | 1033篇 |
出版年
2024年 | 74篇 |
2023年 | 555篇 |
2022年 | 1009篇 |
2021年 | 1436篇 |
2020年 | 1292篇 |
2019年 | 1091篇 |
2018年 | 1124篇 |
2017年 | 1037篇 |
2016年 | 1046篇 |
2015年 | 1107篇 |
2014年 | 2092篇 |
2013年 | 2292篇 |
2012年 | 1904篇 |
2011年 | 2129篇 |
2010年 | 1764篇 |
2009年 | 1665篇 |
2008年 | 1756篇 |
2007年 | 1839篇 |
2006年 | 1646篇 |
2005年 | 1391篇 |
2004年 | 1256篇 |
2003年 | 1225篇 |
2002年 | 996篇 |
2001年 | 887篇 |
2000年 | 748篇 |
1999年 | 689篇 |
1998年 | 719篇 |
1997年 | 741篇 |
1996年 | 637篇 |
1995年 | 543篇 |
1994年 | 499篇 |
1993年 | 452篇 |
1992年 | 441篇 |
1991年 | 417篇 |
1990年 | 376篇 |
1989年 | 334篇 |
1988年 | 289篇 |
1987年 | 255篇 |
1986年 | 215篇 |
1985年 | 285篇 |
1984年 | 246篇 |
1983年 | 143篇 |
1982年 | 240篇 |
1981年 | 213篇 |
1980年 | 161篇 |
1979年 | 147篇 |
1978年 | 144篇 |
1977年 | 126篇 |
1976年 | 111篇 |
1975年 | 43篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
《Journal of infection and chemotherapy》2022,28(4):548-553
IntroductionCOVID-19 patients have been reported to have digestive symptoms with poor outcome. Ivermectin, an antiparasitic drug, has been used in COVID-19 patients. The objective of this study was to evaluate whether ivermectin has effects on gastrointestinal complications and ventilator-free days in ventilated patients with COVID-19.MethodsCOVID-19 patients who were mechanically ventilated in the ICU were included in this study. The ventilated patients who received ivermectin within 3 days after admission were assigned to the Ivermectin group, and the others were assigned to the Control group. Patients in the Ivermectin group received ivermectin 200 μg/kg via nasal tube. The incidence of gastrointestinal complications and ventilator-free days within 4 weeks from admission were evaluated as clinical outcomes using a propensity score with the inverse probability weighting method.ResultsWe included 88 patients in this study, of whom 39 patients were classified into the Ivermectin group, and 49 patients were classified into the Control group. The hazard ratio for gastrointestinal complications in the Ivermectin group as compared with the Control group was 0.221 (95% confidence interval [CI], 0.057 to 0.855; p = 0.029) in a Cox proportional-hazard regression model. The odds ratio for ventilator-free days as compared with the Control group was 1.920 (95% CI, 1.076 to 3.425; p = 0.027) in a proportional odds logistic regression model.ConclusionsIvermectin improved gastrointestinal complications and the number of ventilator-free days in severe COVID-19 patients undergoing mechanical ventilation. Prevention of gastrointestinal symptoms by SARS-Cov-2 might be associated with COVID-19 outcome. 相似文献
4.
Phoebe Hammer Kevin White Stephanie Mengden Vessy Korcheva Philipp W. Raess 《Journal of cutaneous pathology》2019,46(5):343-346
Cutaneous leiomyomas are rare benign smooth‐muscle tumors. These lesions are distinguished based on their cell of origin and are subclassified as pilar leiomyoma, angioleiomyoma, and genital‐type leiomyoma. Nipple leiomyoma is the least common genital‐type leiomyoma, arising from the dartoic muscle cell of the nipple. Histologic examination of the lesion is necessary for definitive diagnosis, and these uncommon tumors can pose a diagnostic challenge. We describe herein a series of six nipple leiomyomas with a spectrum of histologic appearances. 相似文献
5.
目的探究面肌痉挛患者微血管减压术(MVD)中异常肌反应(AMR)的变化特点与术后疗效的关系。方法回顾性分析73例MVD术中采用AMR全程定量化监测患者的AMR变化特点,减压操作前AMR阈值较基础阈值升高≥1倍为A1组、1倍为A2组,手术结束时AMR完全消失为B1组、未消失为B2组,B2组中AMR阈值较基础阈值升高≥1倍为B2a组、1倍为B2b组,对各组的术后疗效进行对比分析。结果 A1组21例中,19例立即治愈,1例延迟治愈,1例未愈; A2组52例中,35例立即治愈,9例延迟治愈,8例未愈。A1组较A2组疗效好(P=0. 046)。B1组50例中,42例立即治愈,5例延迟治愈,3例未愈; B2组23例中,12例立即治愈,5例延迟治愈,6例未愈。B1组较B2组疗效好(P=0. 003)。B2 a组的治愈比例较B2 b组高(分别为14/16、3/7),差异有统计学意义(P=0. 045)。结论 AMR在术中的变化特点对术者有重要参考意义,AMR在减压前升高、在手术结束时完全消失、未消失但升高较基础阈值≥1倍者术后疗效相对较好。 相似文献
6.
7.
8.
《Pediatric clinics of North America》2015,62(6):1463-1477
9.
《Clinical gastroenterology and hepatology》2022,20(3):e380-e397
- Download : Download high-res image (232KB)
- Download : Download full-size image
10.
《Clinical neurophysiology》2020,131(1):259-264
ObjectivesFasciculation potentials (FP) are an important consideration in the electrophysiological diagnosis of ALS. Muscle ultrasonography (MUS) has a higher sensitivity in detecting fasciculations than electromyography (EMG), while in some cases, it is unable to detect EMG-detected fasciculations. We aimed to investigate the differences of FP between the muscles with and without MUS-detected fasciculations (MUS-fas).MethodsThirty-one consecutive patients with sporadic ALS were prospectively recruited and in those, both needle EMG and MUS were performed. Analyses of the amplitude, duration, and number of phases of EMG-detected FPs were performed for seven muscles per patient, and results were compared between the muscles with and without MUS-fas in the total cohort.ResultsThe mean amplitude and phase number of FP were significantly lower in patients with EMG-detected FP alone (0.39 ± 0.25 mV and 3.21 ± 0.88, respectively) than in those with both FP and MUS-fas (1.22 ± 0.92 mV and 3.74 ± 1.39, respectively; p < 0.0001 and p = 0.017, Welch’s t-test).ConclusionSmall FP may be undetectable with MUS. MUS cannot replace EMG in the diagnostic approach for ALS.SignificanceClinicians should use a combination of EMG and MUS for the detection and quantitative analysis of fasciculation in ALS. 相似文献